Lymphoma News

imbruvica.jeg_.jpeg
Well ahead of schedule, the US Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat...
novartis_0.png
Pharmaceutical giant Novartis has become the first company in the pharma industry to file an application with the FDA for app...
fda-logo.jpg
The U.S. Food and Drug Administration today has approved Zydelig (idelalisib) for the treatment of patients with three types...
bcell-image.jpg
Five year survival rates for many blood cancers have been rising over the past 15 years in Europe, according to a major regis...
LLS logo.jpg
The Leukemia & Lymphoma Society has updated their publications on acute lymphoblastic leukemia (ALL). Access these update...
lab-work.jpg
According to researchers from Cardiff University's School of Medicine, prognosis in patients with chronic lymphocytic leukemi...
chemo treatment NCI.jpg
According to the final analysis of the German Hodgkin Study Group HD13 trial, neither dacarbazine nor bleomycin can be taken...
boehringer.png
Results from a Phase II study demonstrated patients with previously untreated acute myeloid leukemia (AML) aged 65 or older a...
ct-scan-machine.jpg
New research indicates that patients with non-Hodgkin's lymphoma who undergo eight or more CT scans double their risk for sec...
novartis_0.png
Novartis has announced that the US Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investi...

LymphomaInfo Social